MARC details
000 -LEADER |
fixed length control field |
03071nam a22003737a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
221213s20222022 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1045-3873 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1111/jce.15733 [doi] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
36335642 |
245 ## - TITLE STATEMENT |
Title |
Dofetilide use is not associated with increased mortality in patients with left ventricular hypertrophy and atrial fibrillation. |
251 ## - Source |
Source |
Journal of Cardiovascular Electrophysiology. 2022 Nov 06 |
252 ## - Abbreviated Source |
Abbreviated source |
J Cardiovasc Electrophysiol. 2022 Nov 06 |
253 ## - Journal Name |
Journal name |
Journal of cardiovascular electrophysiology |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2023 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Publication date |
2022 Nov 06 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
aheadofprint |
266 ## - Date added to catalog |
Date added to catalog |
2022-12-13 |
501 ## - WITH NOTE |
Local holdings |
Available online through MWHC library: 2007 -2010, Available in print through MWHC library: 1999 - 2006 |
520 ## - SUMMARY, ETC. |
Abstract |
BACKGROUND: Left ventricular hypertrophy (LVH) is common in patients with atrial fibrillation (AF), however, many antiarrhythmic drugs (AADs) are contraindicated. US guidelines recommend avoiding pure class III antiarrhythmics such as dofetilide in patients with significant LVH due to concern for an increased risk of death, however, clinical data is lacking. We sought to determine if dofetilide use was associated with increased mortality in patients with LVH. |
520 ## - SUMMARY, ETC. |
Abstract |
CONCLUSIONS: In a propensity-matched cohort of 718 patients with AF and LVH, dofetilide was not associated with increased mortality at 3 years. Our study adds to prior data demonstrating the safety of dofetilide in this population despite guideline recommendations against its use. Given the limited options for AF management in LVH patients, dofetilide may be reasonable for symptomatic AF management. Copyright © 2022 Wiley Periodicals LLC. |
520 ## - SUMMARY, ETC. |
Abstract |
METHODS: Patients >=18 years of age with AF and LVH >= 1.4 cm were included. A group of patients treated with dofetilide and a control group of patients without a history of AAD use were propensity matched. The primary outcome was all-cause mortality at 3 years and secondary outcomes were total number of all-cause hospitalizations and hospitalizations related to AF. |
520 ## - SUMMARY, ETC. |
Abstract |
RESULTS: There were 359 patients in each of the groups. Baseline variables were well-matched. The primary outcome of all-cause mortality occurred in 7% of patients in the dofetilide group and 12% of patients in the control group (hazard ratio: 0.90, 95% confidence interval: 0.53-1.53). Total all-cause hospitalizations were higher in the control group but hospitalizations for AF were no different. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Washington Hospital Center |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine/Internal Medicine |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Mehdi, Noor-Ul-Huda A |
Institution Code |
MWHC |
790 ## - Authors |
All authors |
and other members of the UPMC Study Group, Bhonsale A, Estes NM, Jain SK, Medoff BS, Mehdi NA, Mulukutla S, Saba S, Sezer A, Thoma FW, Wann DG |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1111/jce.15733">https://dx.doi.org/10.1111/jce.15733</a> |
Public note |
https://dx.doi.org/10.1111/jce.15733 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |